Zealand Pharma A/s buy BiotechBee
Start price
01.10.24
/
70%
€109.30
Target price
31.12.27
€150.00
Performance (%)
-2.47%
End price
14.12.24
€106.60
Summary
This prediction ended on 14.12.24 with a price of €106.60. With a performance of -2.47%, the BUY prediction for Zealand Pharma A/s by BiotechBee closed slightly in the red. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Zealand Pharma A/s | -8.900% | -8.900% | -42.316% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
According to BiotechBee what are the pros and cons of Zealand Pharma A/s for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Zealand Pharma A/s diskutieren
Buy mit Kursziel 150,0